Close Menu

Five UK organizations are calling for further discussions about the potential use of gene editing technologies such as CRISPR/Cas-9 for human germline editing, even as some are calling for a ban on the technology for such purposes.  

In a statement issued today, the organizations say that while UK law prohibits germline editing for clinical purposes, "there may be future potential to apply genome editing in a clinical context using human germ cells or embryos." 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.